openPR Logo
Press release

Rising Prevalence Of Infectious Diseases Propelling Immunodiagnostics Market Growth Driver: Leading Transformation in the Immunodiagnostics Market in 2025

03-03-2025 12:44 PM CET | Health & Medicine

Press release from: The Business Research Company

Immunodiagnostics Market

Immunodiagnostics Market

What industry-specific factors are fueling the growth of the immunodiagnostics market?
The growth of the immunodiagnostics market is anticipated to be propelled by the growing incidence of infectious diseases. Infectious diseases are conditions that can be passed from person to person and are caused by microorganisms such as viruses, bacteria, fungi, or parasites. The immunodiagnostic test is used to detect a virus in a blood sample. For example, the Centers for Disease Control and Prevention, a government agency in the US, reported in March 2024 that the number of tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, highlighting a growth of 1,295 cases. Therefore, the escalating incidence of infectious diseases is projected to spur the immunodiagnostics market.

Get Your Immunodiagnostics Market Report Here:
https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report

What Is the projected market size and growth rate for the immunodiagnostics market?
In recent times, there has been impressive growth in the size of the immunodiagnostics market. It is projected to increase from $22.88 billion in 2024 to $24.54 billion in 2025, displaying a compound annual growth rate (CAGR) of 7.3%. The factors that explain the growth during the historic period include a surge in infectious diseases, an uptick in autoimmune diseases, cancer diagnosis and surveillance, the spread of infectious diseases due to globalization, initiatives in public health, and screening programs.

In the years to come, there is an expected substantial increase for the immunodiagnostics market. The market is anticipated to reach "$33.14 billion by 2029, expanding at a compound annual growth rate (CAGR) of 7.8%. Factors contributing to the predicted advancement during this period include the world's response and preparation for pandemics, the emergence of personalized medicine and biomarker discovery, and the expansion of the healthcare infrastructure in developing markets. The integration with laboratory information systems and the growing prevalence of chronic diseases also drive this growth. Future trends include the incorporation of multiplexing technologies, point-of-care testing (POCT), biomarker discovery, and personalized medicine. The digitalization of immunodiagnostics and a shift towards liquid biopsy are also on the rise.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10093&type=smp

What new trends are reshaping the immunodiagnostics market and its opportunities?
Prominent players in the immunodiagnostics marketplace are concentrating on the creation of progressive solutions such as the S. pneumoniae antigen immunodiagnostic assay, tailored to assist in diagnosing pneumococcal pneumonia infection. This assay functions by recognizing the S. pneumoniae antigens within bodily fluids, encouraging the detection of pneumococcal infections. In a case in point, DiaSorin S.p.A., an Italian biotech company, initiated the LIAISON S. pneumoniae antigen immunodiagnostic assay in September 2024. Designed for the qualitative identification of Streptococcus pneumoniae antigens in adult urine samples, this diagnostic test helps differentiate pneumococcal pneumonia from other respiratory infections. Operating through LIAISON CLIA analyzers, this test delivers results within 35 minutes, enabling swift and specific antimicrobial treatments. Its capacity to determine 91 serotypes aids in clinical judgment and enhances antibiotic stewardship effectively, marking a remarkable breakthrough in the domain of immunodiagnostics for community-originated pneumonia.

What major market segments define the scope and growth of the immunodiagnostics market?
The immunodiagnostics market covered in this report is segmented -

1) By Product: Reagents And Consumables, Instruments, Software And Services
2) By Technology: Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay, Rapid Test, Other Technologies
3) By Application: Infectious Diseases, Oncology And Endocrinology, Bone And Mineral Diseases, Autoimmunity Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications
4) By End User: Hospitals, Clinics, Diagnostic Laboratories, Academic And Research Institutes, Other End Users

Subsegments:
1) By Reagents And Consumables: Antibodies, Assay Kits, Buffers And Substrates
2) By Instruments: Immunoassay Analyzers, Flow Cytometers, ELISA Readers
3) By Software And Services: Laboratory Information Management Systems (LIMS), Data Analysis Software, Maintenance And Support Services

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10093

Which region dominates the immunodiagnostics market?
North America was the largest region in the immunodiagnostics market in 2024. The regions covered in the immunodiagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Which key market leaders are driving the immunodiagnostics industry growth?
Major companies operating in the immunodiagnostics market include Abbott Laboratories, Arkray Inc., bioMérieux Inc., Immunodiagnostic Systems Holdings Plc (IDS), Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Johnson & Johnson Services Inc., Siemens AG, Sysmex Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Qiagen N.V., Tecan Trading AG, PerkinElmer Inc., Merck KGaA, Becton Dickinson and Company, Grifols S.A., Ortho Clinical Diagnostics, Beckman Coulter Inc., Bio-Techne Corporation, Creative Diagnostics, Fujirebio Holdings Inc., Gold Standard Diagnostics Corp., Hologic Inc., Luminex Corporation, Myriad Genetics Inc., Natera Inc., OraSure Technologies Inc., Quidel Corporation

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10093&type=smp

What Is Covered In The Immunodiagnostics Global Market Report?

• Market Size Forecast: Examine the immunodiagnostics market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the immunodiagnostics market for a structured understanding.
• Key Players Overview: Analyze major players in the immunodiagnostics market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the immunodiagnostics market.
• Segment Contributions: Evaluate how different segments drive overall growth in the immunodiagnostics market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the immunodiagnostics market.
• Industry Challenges: Identify potential risks and obstacles affecting the immunodiagnostics market.
• Competitive Landscape: Review strategic developments in the immunodiagnostics market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rising Prevalence Of Infectious Diseases Propelling Immunodiagnostics Market Growth Driver: Leading Transformation in the Immunodiagnostics Market in 2025 here

News-ID: 3894582 • Views:

More Releases from The Business Research Company

Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Forecast Report
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025? The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of
Sustained Release Excipients Market Advances With Product Innovation Industry Trends Gaining Momentum in the Global Sustained Release Excipients Market
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therapeutics Market Driving Market Acceleration in the RNA Targeting Small Molecules Therapeutics Industry, 2025
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025? In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as a Core Driver of the Remicade Biosimilar Market in 2025
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025? In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic

All 5 Releases


More Releases for Immunodiagnostic

Immunodiagnostic Reagent Market Analysis and Future Prospects for 2030
The world of the immunodiagnostic reagent market is a complex and ever-evolving landscape, shaped by consumer demands and technological advancements. In this report, we delve into the depths of this market to provide a profound and comprehensive analysis, catering to a diverse audience that includes manufacturers, suppliers, distributors, and investors. Our primary goal is to empower industry stakeholders with invaluable insights to make informed decisions in a rapidly changing environment.
Immunodiagnostic Market Research Report with Global Analysis and Forecast by 202 …
The "Immunodiagnostic market" is expected to grow from US$ 17,948.62 million in 2021 to US$ 29,526.72 million by 2028; it is estimated to grow at a CAGR of 7.4% from 2022 to 2028. The increasing prevalence of infectious diseases and the growing use of point-of-care immunodiagnostics are the factors fueling the global immunodiagnostic market growth. However, factors such as inadequate treatment reimbursement scenarios are restraining the market growth. Get a Sample PDF
Immunodiagnostic System Market (2023-2030) : In-Depth Industry Analysis on Size, …
The latest report on the Immunodiagnostic System Market 2023-2030 provides a comprehensive overview of the industry's important characteristics, including production, market growth rate, industry share, consumption value, volume, demand for specific types of products and services, and more. The publication focuses on providing a competitive advantage to industry newcomers and those who aim to enter the market in the next years. It offers information on the most recent consolidations, acquisitions,
Immunodiagnostic System Market by Trends, Dynamic Innovation in Technology and 2 …
Secondary research techniques are employed to do the clear Immunodiagnostic System market analysis. Some useful insights into major companies, their profiles, key strategies, financial status and trending developments are provided in this market analysis report. Trend analysis, pricing analysis customer buying habits and competitive analysis for the estimation period 2022-2028 is also provided in this market analysis. Basic and advanced data regarding market growth is depicted. This illustrative Immunodiagnostic System
Global Immunodiagnostic System Market Growth, Trends and Forecast 2021 to 2027 - …
Global Immunodiagnostic System Market Research Report 2021-2027 is the latest research study published by Market Research Place that aims to gather, record, and analyze the data for the concerns linked to the marketing of goods and services and thereby serve the global industry with an excellent market research report. The report identifies industry trends, determines brand awareness and influence, provides industry insights, and offers competitive intelligence. This report carries out
Immunodiagnostic System Market size to increase at a Sustainable Growth Rate dur …
The Immunodiagnostic System Market is expected to grow at a CAGR of 7.6%. The factors leading to this extraordinary growth is attributed to various market dynamics discussed in the report. Our experts have examined the market from a 360 degree perspective thereby producing a report which is definitely going to impact your business decisions. To avail Sample Copy of report, visit @ https://www.decisivemarketsinsights.com/immunodiagnostic-system-market/09671876/request-sample Key Companies Operating in this Market Ortho-Clinical Diagnostics Immunodiagnostic Systems (IDS) Abbott